Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
sanofi
5
×
national top stories
new york blog main
new york top stories
biotech
clinical trials
deals
san francisco blog main
san francisco top stories
alirocumab
amgen
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
evolocumab
fda
glaxosmithkline
inclisiran
indiana blog main
indiana top stories
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
new
5
×
medicines
bio
cholesterol
deal
drug
known
molecules
wave
acquire
address
adds
ago
agreed
allosteric
bets
billion
biopharma
brings
cancer
cash
clinic
comes
companies
company
compound
congress
congressional
crispr
cut
date
disease
drugs
effective
elusive
enticed
evidence
executives
expensive
faces
Language
unset
Current search:
sanofi
×
new
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines